These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7951167)

  • 21. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
    Gavras I; Gavras H
    Curr Med Res Opin; 1999; 15(1):15-24. PubMed ID: 10216807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of levonorgestrel and ethinyloestradiol on vasoconstriction in rat isolated vasculature.
    Byrne KB; Stanton BJ; Coupar IM; Burcher E
    J Pharm Pharmacol; 1988 Aug; 40(8):562-6. PubMed ID: 2907011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
    Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
    Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion.
    Mansuri A; Elmaghrabi A; Legan SK; Gattineni J; Baum M
    PLoS One; 2015; 10(12):e0146183. PubMed ID: 26719973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptives--induced hypertension--nine years later.
    Laragh JH
    Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma renin activity and angiotensin II during oral contraception.
    Soveri P; Fyhrquist F
    Ann Clin Res; 1977 Dec; 9(6):346-9. PubMed ID: 616222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL; Gutkowska J; Thibault G; Genest J
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
    Goldberg MR; Bradstreet TE; McWilliams EJ; Tanaka WK; Lipert S; Bjornsson TD; Waldman SA; Osborne B; Pivadori L; Lewis G
    Hypertension; 1995 Jan; 25(1):37-46. PubMed ID: 7843751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced slow pressor effect of angiotensin II in two-kidney, one clip rats.
    Melaragno MG; Fink GD
    Hypertension; 1995 Feb; 25(2):288-93. PubMed ID: 7843781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oral contraceptives on the renin-angiotensin system and on blood pressure of normal young women.
    Beckerhoff R; Luetscher JA; Beckerhoff I; Nokes GW
    Johns Hopkins Med J; 1973 Feb; 132(2):80-7. PubMed ID: 4346163
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of oral contraceptives on plasma renin activity and plasma renin substrate concentration (author's transl)].
    Kaulhausen H; Oehm W; Fritzsche G; Breuer H
    Z Klin Chem Klin Biochem; 1974 Sep; 12(9):408-14. PubMed ID: 4372825
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin II regulates renin gene expression.
    Johns DW; Peach MJ; Gomez RA; Inagami T; Carey RM
    Am J Physiol; 1990 Dec; 259(6 Pt 2):F882-7. PubMed ID: 2260680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
    Larsson-Cohn U; Wallentin L; Zador G
    Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
    Nichols M; Robinson G; Bounds W; Newman B; Guillebaud J
    Contraception; 1993 Apr; 47(4):367-76. PubMed ID: 8508666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.